| CTRI Number |
CTRI/2018/03/012550 [Registered on: 13/03/2018] Trial Registered Retrospectively |
| Last Modified On: |
07/03/2018 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
observational study |
| Study Design |
Other |
|
Public Title of Study
|
Unani medicine Habb-e-Sandroos for piles |
|
Scientific Title of Study
|
Efficacy of Habb-e-Sandroos in Bawaseer Ghaira (Internal Hemorrhoids) |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr mehjabeen fatimah |
| Designation |
lecturer |
| Affiliation |
national institute of unani medicine |
| Address |
national institute of unani medicine,
Bangalore KARNATAKA 560091 India |
| Phone |
08057438462 |
| Fax |
|
| Email |
fatimahmehjabeen@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr mehjabeen fatimah |
| Designation |
lecturer |
| Affiliation |
national institute of unani medicine |
| Address |
national institute of unani medicine, bangalore-91
Bangalore KARNATAKA 560091 India |
| Phone |
08057438462 |
| Fax |
|
| Email |
fatimahmehjabeen@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Mahfooz Alam |
| Designation |
P.G.Scholar |
| Affiliation |
national institute of unani medicine |
| Address |
national institute of unani medicine,
kottegipalya, bangalore-91 Bangalore KARNATAKA 560091 India |
| Phone |
8050014042 |
| Fax |
|
| Email |
drmahznium@gmail.com |
|
|
Source of Monetary or Material Support
|
| Mational Institute of Unani medicine, kottigepalya, bangalore-91 |
|
|
Primary Sponsor
|
| Name |
National Institute of Unani medicine |
| Address |
kottigepalya, bangalore-91, karnataka |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Mahfooz Alam |
National Institute of Unani Medicine And Hospital |
Dept of Surgery, Room 54 (Operation Theatre) Bangalore KARNATAKA |
8050014042
drmahznium@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| IEC |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
suffering from bawaseer-e-Ghaira(internal hemorrhoids), |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Habb-e-Samdroos |
Hab-e-Sandroos, 2 tablets each weighing 0.5g, thrice in a day for the duration of
protocol. |
|
|
Inclusion Criteria
|
| Age From |
20.00 Year(s) |
| Age To |
65.00 Year(s) |
| Gender |
Both |
| Details |
1.Diagnosed patients of Ist and IInd degree hemorrhoid confirmed by proctoscopy.
2.Patients of either sex.
3.Patients of 20-65 years of age.
4.Controlled Hypertensive Patients.
5.Controlled Diabetic Patients.
ï‚· Patients willing to participate in the study and ready to follow the protocol. |
|
| ExclusionCriteria |
| Details |
1. III and IV degree internal hemorrhoids.
2. Patients with bleeding disorders.
3. Pregnant and lactating women.
4. Severe systemic illnesses. |
|
|
Method of Generating Random Sequence
|
Other |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Participant Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
amount of bleeding
regression of pile mass(grade-1, 2, 3, 4)
bleeding points
|
0 day,
15th day
30th day
45th day
After 1 month after protocol duration (after 1month by completing 45days)
After 2 months by completing protocol duration |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
Mucus discharge (mild moderate severe
mild moderate severe)
Itching |
0 daay
15 day
30 day
45 day
1 month after completing protocol
2 months after completing protocol |
|
|
Target Sample Size
|
Total Sample Size="30" Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "30"
Final Enrollment numbers achieved (India)="30" |
|
Phase of Trial
|
Phase 2 |
|
Date of First Enrollment (India)
|
01/08/2015 |
| Date of Study Completion (India) |
01/01/2017 |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
01/01/2017 |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Completed |
|
Publication Details
|
not yet
|
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
|
Brief Summary
|
this clinical study entitled “Efficacy of Habb-e-Sandroos in Bawaseer Ghaira (Internal Hemorrhoids)†was conducted at OPDs and IPDs of National Institute of Unani Medicine hospital, Bengaluru from August 2015 to January 2017. This was executed after the approval of study protocol by Institutional Ethical Committee NIUM, Bangaluru under IEC No: NIUM/IEC/2014-15/JAR/01. The studies showed that majority of the patients were in the range (21-40) years of age. The Mean age was found to be 36.90 with SD ± 9.86. They were predominantly males. In which 80% patients were married and 33.3 % among them were having familial history. Most of them were from labour class i.e lower middle class who were using less fibrous diet, increased use of non-veg and junk food. They were having unsatisfactory bowel,constipation, passing of hard stool, straining at stool and more stay-time in toilets were completely relieved. The subjective complaints of bleeding pre-rectum, mucus discharge, pruritus ani (itching), and prolapse of pile mass were completely relived at the end of protocol with significant p-value 0.001, 0.026, 0.003 and 0.001 respectively. In the objective parameters of bleeding during examination, 80% patients were having bleeding. They showed complete relived at the end of protocol i.e 100% with significance p-value 0.001. All patients had bleeding points which were disappeared at the end of 4th follow-up with significant p-value <0.001. Out of total 83 number of primary pile masses, 32 piles masses were of grade-I and 51 pile masses were of grade-II. In grade-I primary pile mass out of 32 pile masses, 31 pile masses were relieved at the end of protocol i.e 96.88%. Overall 22 patients got completely relieved. Whereas as in grade-II pile mass group, out of 51 pile mass 38 pile mass collectively were completely disappeared i.e 74.51% (38) at the end of protocol period with p-value 0.011 moderately significant. Out of this 38 pile masses, the number of piles relieved at different positions 3, 7 and 11 O`clock were 7, 16, and 15 respectively. Overall 16 patients i.e. 31.37% were got fully cured. No report of recurrence after the end of protocol. Among all the affected patients with sphincter spasm, 94.73% were got relief. It was found that majority of patients were from Damvi mizaj followed by Balghami and Safravi mizaj. Both Damvi and Balghami mizaj patients were common sufferers. They together constituted 80% of the affected patients. No patients of saudavi mizaj come under our study.
The study is not the final and complete evaluation of the test drug but an initiation to provide base for further studies on bleeding disorders, platelet count, PPT, wound healing, collagen formation rate and muscular flaccidity or toning. |